awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52326653-99E23960-AE96-492E-83CD-0E713865479C
Q52326653-99E23960-AE96-492E-83CD-0E713865479C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52326653-99E23960-AE96-492E-83CD-0E713865479C
Sofosbuvir + velpatasvir + voxilaprevir for the treatment of hepatitis C infection.
P2860
Q52326653-99E23960-AE96-492E-83CD-0E713865479C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52326653-99E23960-AE96-492E-83CD-0E713865479C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9efbbdf596fff869d1e5e169770e0fe453213f73
P2860
Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.